Addressing the burden of group A streptococcal disease in India.
Indian J Pediatr
;
2004 Jan; 71(1): 41-8
Article
in English
| IMSEAR
| ID: sea-80015
ABSTRACT
Group A streptococcus-associated disease and sequelae continue to have devastating effects on public health and national economy as they mainly affect children and young adults. There is an urgent need for wider application of methods of primary prevention, in the form of optimal diagnosis and management of the simple group A streptococcal sore throat. This review article briefly summarizes the burden of streptococcal disease in India, and discusses treatment options standardized by the World Health Organization. Penicillin continues to remain the drug of choice for treating group A streptococcal pharyngitis and for prevention of acute rheumatic fever in non-allergic patients. Also discussed in this review are contemporary thoughts on streptococcal "carriers", recurrent infections, antibiotic treatment "failures" and emergence of drug resistance among group A streptococci.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Streptococcal Infections
/
Streptococcus pyogenes
/
Female
/
Humans
/
Male
/
Carrier State
/
Microbial Sensitivity Tests
/
Child
/
Child, Preschool
/
Incidence
Type of study:
Etiology study
/
Incidence study
/
Prognostic study
/
Risk factors
Country/Region as subject:
Asia
Language:
English
Journal:
Indian J Pediatr
Year:
2004
Type:
Article
Similar
MEDLINE
...
LILACS
LIS